Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

LexaGene Holdings Inc. Completes $5.75 Million Bought Deal Financing Underwriters Exercise Over-Allotment Option in Full

Canada NewsWire July 11, 2018

LexaGene Holdings Inc. Announces C$5.0 Million Bought Deal

Canada NewsWire June 19, 2018

LexaGene Names Medical Device Veteran Joseph Caruso to Board of Directors

GlobeNewswire June 18, 2018

LexaGene Announces Collaboration with Texas A&M Veterinary Medical Diagnostics Laboratory

GlobeNewswire June 6, 2018

LexaGene Enters Collaboration to Incorporate Cancer Sequencing Technology into a New Product

GlobeNewswire May 29, 2018

LexaGene’s Prototype for Better Pathogen Detection Now Capable of Identifying E. coli and Staph

GlobeNewswire May 15, 2018

LexaGene Announces Collaboration with Ethos Veterinary Health

GlobeNewswire April 4, 2018

LexaGene Appoints New Chief Financial Officer

GlobeNewswire March 1, 2018

LexaGene Honored as a Top 50-Ranked TSX Venture Company

GlobeNewswire February 22, 2018

LexaGene Grants Compensation Awards

GlobeNewswire February 21, 2018

LexaGene Leases Larger Space to Support Company Growth

GlobeNewswire February 6, 2018

LexaGene Appoints Greg Dale to Vice President of Product Development and Manufacturing

GlobeNewswire January 25, 2018

LexaGene Holdings Inc. Announces Closing of Over-Allotment Option

GlobeNewswire January 22, 2018

LexaGene Holdings Inc. Announces Closing of C$5.0 Million Bought Deal Financing

GlobeNewswire December 19, 2017

LexaGene Announces Refiling of Annual Information Form

GlobeNewswire December 4, 2017

LexaGene Completes Prototype Assembly for Soon-To-Be First Fully Automated, Open-Access Pathogen Detection System

GlobeNewswire November 30, 2017

IIROC Trade Resumption - Lexagene Holdings Inc.

Newsfile November 29, 2017

IIROC Trading Resumption - LXG

Canada NewsWire November 29, 2017

LexaGene Holdings Inc. Announces C$5.0 Million Bought Deal

Canada NewsWire November 28, 2017

IIROC Trading Halt - LXG

Canada NewsWire November 28, 2017